Bill > HB1133

This bill updates Hawaii's Uniform Controlled Substance Act to align with federal regulations by modifying several sections of the state's drug classification statutes. Specifically, the bill amends Section 329-14 to add numerous new synthetic opioids and hallucinogenic substances to Schedule I, including compounds with complex chemical names like brorphine, etodesnitazene, and alpha'-methyl butyryl fentanyl. The bill also updates Section 329-20 to modify Schedule IV by adding a new substance called zuranolone, removing the section on fenfluramine, and reorganizing the existing subsections. Additionally, the bill renumbers and adjusts various stimulant and narcotic drug listings within the schedule. The changes are designed to keep Hawaii's controlled substance regulations current with emerging drug trends and federal classifications, ensuring that new synthetic drugs and potentially dangerous substances are appropriately regulated and controlled. The bill will take effect immediately upon approval by the appropriate authorities.

Health and Social Services

https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=1133&year=2026